Correlation Significance level Patients (n) | ETS | LOT-R Optimism | LOT-R Pessimism | PHQ-9 | RS-11 | BEE | PSM | NEO-FFI Neuroticism | NEO-FFI Openness to experience |
ETS | 1 | ||||||||
102 | |||||||||
LOT-ROptimism | −0.066 | 1 | |||||||
0.517 | |||||||||
99 | 99 | ||||||||
LOT-RPessimism | 0.204* | −0.247* | 1 | ||||||
0.043 | 0.014 | ||||||||
99 | 99 | 99 | |||||||
PHQ-9 | 0.233* | −0.567† | 0.312† | 1 | |||||
0.02 | 0 | 0.002 | |||||||
100 | 99 | 99 | 100 | ||||||
RS-11 | −0.073 | 0.546† | −0.460† | −0.572† | 1 | ||||
0.474 | 0 | 0 | 0 | ||||||
99 | 99 | 99 | 99 | 99 | |||||
BEE | 0.032 | 0.259† | −0.074 | −0.176 | 0.407† | 1 | |||
0.754 | 0.01 | 0.468 | 0.081 | 0 | |||||
99 | 99 | 99 | 99 | 99 | 99 | ||||
PSM | 0.344† | −0.078 | 0.201* | 0.306† | −0.049 | 0.011 | 1 | ||
0 | 0.445 | 0.046 | 0.002 | 0.631 | 0.912 | ||||
100 | 99 | 99 | 100 | 99 | 99 | 100 | |||
NEO-FFI | 0.104 | −0.578† | 0.467† | 0.631† | −0.682† | −0.284† | 0.238* | 1 | |
Neuroticism | 0.316 | 0 | 0 | 0 | 0 | 0.005 | 0.02 | ||
95 | 95 | 95 | 95 | 95 | 95 | 95 | 95 | ||
NEO-FFI | −0.072 | 0.297† | −0.167 | −0.09 | 0.302† | 0.122 | 0.132 | −0.13 | 1 |
Openness to experience | 0.492 | 0.004 | 109 | 0.386 | 0.003 | 0.241 | 0.205 | 0.211 | |
94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | |
Cronbach’s alpha | 0.901 | 0.727 | 0.608 | 0.9 | 0.9 | 0.757 | 0.94 | 0.854 | 0.726 |
*Correlation is significant at the 0.05 level (two tailed).
†Correlation is significant at the 0.01 level (two tailed).
BEE, Body Efficacy Expectation; ETS, Expectation for Treatment Scale; LOT-R, Life Orientation Test; NEO-FFI, NEO Five-Factor Inventory; PHQ-9, Patient Health Questionnaire-9; PSM, Perceived Sensitivity to Medicines Scale; RS-11, Die Resilienzskala-Ein Fragebogen zur Erfassung der psychischen Widerstandsfähigeit als Personenmerkmal.